Journals / Turkish archives of pediatrics (Online) / 2021 / Cilt: 56 - Sayı: 4

The Effect of Allergen Immunotherapy on the Development of New Sensitization in Children

Pages
374–379
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, this effect was insignificant in the multivariate analysis.Weed pollen sensitization and the presence of asthma are related to the development of newsensitization.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The protective effect of allergen immunotherapy against a new allergic sensitization iscontroversial.
📊
Key Findings & Data:This study aimed to investigate the effect of allergen immunotherapy on newallergic sensitization in children.Materials and Methods: The study included 50 patients who received immunotherapy for atleast 3 years, and whose skin prick tests were repeated at intervals of at least 3 years (31 patientsfor house dust mite immunotherapy, 19 patients for pollen immunotherapy), and 69 controlswith similar characteristics.Results: The number of patients who developed a new sensitization was similar both in thegroups of patients who received house dust mite and pollen immunotherapy, and the controlgroup.
💡
Conclusion & Impact:However, this effect was insignificant in the multivariate analysis.Weed pollen sensitization and the presence of asthma are related to the development of newsensitization.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: The protective effect of allergen immunotherapy against a new allergic sensitization iscontroversial. This study aimed to investigate the effect of allergen immunotherapy on newallergic sensitization in children.Materials and Methods: The study included 50 patients who received immunotherapy for atleast 3 years, and whose skin prick tests were repeated at intervals of at least 3 years (31 patientsfor house dust mite immunotherapy, 19 patients for pollen immunotherapy), and 69 controlswith similar characteristics.Results: The number of patients who developed a new sensitization was similar both in thegroups of patients who received house dust mite and pollen immunotherapy, and the controlgroup. There was no significant difference between the first and last skin prick tests ofthe patients who received house dust mite and pollen immunotherapy; however, in the controlgroups, a significant increase in sensitivity to tree pollens (n = 2, 5.4%; n = 8, 21.6%) and weedpollens (n = 7, 26.9%; n = 14, 53.8%) was detected (P = .031 and P = .039). While allergen sensitivitiesin the first tests of the pollen immunotherapy group and the control group were similar,weed pollen sensitivity was significantly higher in the last tests of the control group (n = 14,53.8%; n = 4, 21.1%, P = .027). It was determined that the presence of weed pollen sensitization(OR: 8.1, 95% CI: 1.5-42.4) and having asthma (OR: 3.5, 95% CI: 1.3-10.8) increases the risk of newsensitization in all groups.Conclusion: Allergen immunotherapy has been found to protect against new sensitizationto tree and weed pollens. However, this effect was insignificant in the multivariate analysis.Weed pollen sensitization and the presence of asthma are related to the development of newsensitization.

🔖

Cite This Article

ÇEKİÇ, Ş., CANITEZ, Y., ÇİÇEK, F., OCAKOĞLU, G., SAPAN, N. (2021). The Effect of Allergen Immunotherapy on the Development of New Sensitization in Children. Turkish archives of pediatrics (Online), Cilt: 56 - Sayı: 4, 374–379. https://ajindex.com/articles/369996

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clın Immunol. 2011;127(1) (suppl):S1-55. [CrossRef]
  2. Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572-1573
  3. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 1911;178(4594):814-817. [CrossRef]
  4. Des Roches A, Paradis LM, Menardo JL, Bouges S, JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99:450-453. [CrossRef] 5. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006;61(2):198-201. [CrossRef] 6. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children mono-sensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31(9):1392-1397. [CrossRef] 7. Purello-D’Ambrosio F, Gangemi S, Merendino RA et al. Prevention of new sensitizations in mono-sensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy. 2001;31(8):1295-1302. [CrossRef] 8. Inal A, Altintas DU, Yilmaz M, et al. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol. 2007;17:85-91
  5. Asero R. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol. 2004;133(1):49-54. [CrossRef] 10. Asero R. Pollen specific immunotherapy is not a risk factor for de novo sensitization to cross-reacting allergens in monosensitized subjects. J Investig Allergol Clin Immunol. 2006;16:253-257
  6. Harmanci K, Razi CH, Toyran M, Kanmaz G, Cengizlier MR. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol. 2010;28(1):7-13
  7. Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728-745. [CrossRef] 13. Reha CM, Ebru A. Specific immunotherapy is effective in the prevention of new sensitivities. Allergol Immunopathol (Madr). 2007